Seeking Alpha

Alnylam Pharmaceuticals, Inc. (ALNY)

  • wazzaofwallst | Send Message 24 Jun

    Alnylam Pharmaceuticals is in a great financial position, take a look: $ALNY
    Reply (1)
    • matratra | Send Message 24 Jun
      : nope when IBB or IXB are negative
      • Stephen Simpson, CFA | Send Message 12 Jun

        Alnylam's CC5 Data More Like A Long Foul Than A Home-Run Or Strikeout $ALNY
          • Derek Lowe | Send Message 12 Jun

            Alnylam Sues Dicerna $ALNY, $DRNA
              • Mike Zaman | Send Message 11 Jun

                Box Inc (BOX) Better-Than-Expected Numbers; Alnylam (ALNY) Legal Battle Vs Dicerna (DRNA) $BOX, $ALNY, $DRNA
                  • Rod Raynovich | Send Message 14 May

                    Hot Biotech Sector: Mid-Caps Have Both M&A And Pipeline Premiums $ALNY, $PBYI
                      • William Meyers | Send Message 28 Apr

                        Is Alnylam In 2020 Worth $9 Billion Now? $ALNY
                          • Stephen Simpson, CFA | Send Message 23 Apr

                            Alnylam Strengthens Its Clinical Case Once Again $ALNY
                              • StockStatus | Send Message 21 Apr
                                  • StockConsultant | Send Message 5 Mar

                                    $ARWR and $ALNY excellent breakouts this morning, "Stocks to Watch" leaders today
                                    Reply (1)
                                    • matratra | Send Message 5 Mar
                                      : agree for ARWR but is down from $13-$14, which 50% below. I think it is still not worth putting money to work.
                                      • chicagomary | Send Message 12 Feb

                                        $ALNY jumping big% on less loss
                                          Visit Seeking Alpha's
                                          ALNY vs. ETF Alternatives
                                          Company Description
                                          Alnylam Pharmaceuticals Inc is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States